SINGLE-DOMAIN ANTIBODY AGAINST CD16A AND USE THEREOF
The present invention relates to an isolated anti-CD16A single-domain antibody, and a monospecific antibody molecule or a multispecific antibody molecule comprising the anti-CD16A single-domain antibody as a moiety. The present invention also relates to a nucleic acid encoding the anti-CD16A single-...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
28.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to an isolated anti-CD16A single-domain antibody, and a monospecific antibody molecule or a multispecific antibody molecule comprising the anti-CD16A single-domain antibody as a moiety. The present invention also relates to a nucleic acid encoding the anti-CD16A single-domain antibody, the monospecific antibody molecule, or the multispecific antibody molecules, a host cell comprising the nucleic acid, and a method for preparing the anti-CD16A single-domain antibody, the monospecific antibody molecule, or the multispecific antibody molecule. Furthermore, the present invention relates to use of the anti-CD16A single-domain antibody, the monospecific antibody molecule, or the multispecific antibody molecule for the treatment and/or prevention or diagnosis of acute and chronic infectious diseases (e.g., bacterial or viral infections) or a tumor. |
---|---|
Bibliography: | Application Number: US202218262937 |